Trump, Musk Tell USAID: ‘Time to Die’ 03/02/2025 Stefan Anderson The richest man in the world and the President of the United States sent a message over the weekend to USAID, the world’s largest provider of humanitarian assistance depended on for survival by millions of the world’s poorest people: “Time to die.” Two weeks into Donald Trump’s return to the Oval Office, the Washington headquarters […] Continue reading -> RFK Jr Backtracks Anti-Vax Statements at Start of Contentious Confirmation Hearing 29/01/2025 Sophia Samantaroy Robert F Kennedy (RFK) Jr, President Donald Trump’s nominee for the United States Department of Health and Human Services (HHS), faced two days of tense questioning from senators on the finance and health committees. He walked back many of his past statements on vaccines and abortion, and emphasized his commitment to address America’s […] Continue reading -> HIV Clinics Close Across Africa After US Issues ‘Stop-Work Order’ to All Aid Recipients 28/01/2025 Kerry Cullinan Non-governmental organisations that receive US government funds across a range of sectors – including HIV, LGBTQ support and climate change – have been told to cease operations immediately. Over the past two days, letters have been sent to US grant recipients following a “stop-work order” issued late Friday by the US State Department’s Office of […] Continue reading -> Why HIV Could Be Poised for a Monumental Comeback 21/01/2025 Beatriz Grinsztejn & Birgit Poniatowski The good news first: HIV science has made remarkable progress. While we still lack a vaccine or cure, a single dose of a new long-acting injectable drug can now offer protection against HIV for up to six months. This breakthrough could revolutionize efforts to curb a pandemic that still claims a life every minute. However, […] Continue reading -> Unhappy About ‘Woke Agenda’ of PEPFAR, US Conservatives Finally Have Pretext to Cut HIV Funds 19/01/2025 Kerry Cullinan Influential conservatives have long sought to curtail the United States President’s Emergency Plan for AIDS Relief (PEPFAR) – and the actions of four nurses in Mozambique may have inadvertently given them the ammunition to do just that. Deeply uncomfortable with the sexual dimension of HIV transmission, the powerful Heritage Foundation, which authored the conservative Project […] Continue reading -> Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
RFK Jr Backtracks Anti-Vax Statements at Start of Contentious Confirmation Hearing 29/01/2025 Sophia Samantaroy Robert F Kennedy (RFK) Jr, President Donald Trump’s nominee for the United States Department of Health and Human Services (HHS), faced two days of tense questioning from senators on the finance and health committees. He walked back many of his past statements on vaccines and abortion, and emphasized his commitment to address America’s […] Continue reading -> HIV Clinics Close Across Africa After US Issues ‘Stop-Work Order’ to All Aid Recipients 28/01/2025 Kerry Cullinan Non-governmental organisations that receive US government funds across a range of sectors – including HIV, LGBTQ support and climate change – have been told to cease operations immediately. Over the past two days, letters have been sent to US grant recipients following a “stop-work order” issued late Friday by the US State Department’s Office of […] Continue reading -> Why HIV Could Be Poised for a Monumental Comeback 21/01/2025 Beatriz Grinsztejn & Birgit Poniatowski The good news first: HIV science has made remarkable progress. While we still lack a vaccine or cure, a single dose of a new long-acting injectable drug can now offer protection against HIV for up to six months. This breakthrough could revolutionize efforts to curb a pandemic that still claims a life every minute. However, […] Continue reading -> Unhappy About ‘Woke Agenda’ of PEPFAR, US Conservatives Finally Have Pretext to Cut HIV Funds 19/01/2025 Kerry Cullinan Influential conservatives have long sought to curtail the United States President’s Emergency Plan for AIDS Relief (PEPFAR) – and the actions of four nurses in Mozambique may have inadvertently given them the ammunition to do just that. Deeply uncomfortable with the sexual dimension of HIV transmission, the powerful Heritage Foundation, which authored the conservative Project […] Continue reading -> Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
HIV Clinics Close Across Africa After US Issues ‘Stop-Work Order’ to All Aid Recipients 28/01/2025 Kerry Cullinan Non-governmental organisations that receive US government funds across a range of sectors – including HIV, LGBTQ support and climate change – have been told to cease operations immediately. Over the past two days, letters have been sent to US grant recipients following a “stop-work order” issued late Friday by the US State Department’s Office of […] Continue reading -> Why HIV Could Be Poised for a Monumental Comeback 21/01/2025 Beatriz Grinsztejn & Birgit Poniatowski The good news first: HIV science has made remarkable progress. While we still lack a vaccine or cure, a single dose of a new long-acting injectable drug can now offer protection against HIV for up to six months. This breakthrough could revolutionize efforts to curb a pandemic that still claims a life every minute. However, […] Continue reading -> Unhappy About ‘Woke Agenda’ of PEPFAR, US Conservatives Finally Have Pretext to Cut HIV Funds 19/01/2025 Kerry Cullinan Influential conservatives have long sought to curtail the United States President’s Emergency Plan for AIDS Relief (PEPFAR) – and the actions of four nurses in Mozambique may have inadvertently given them the ammunition to do just that. Deeply uncomfortable with the sexual dimension of HIV transmission, the powerful Heritage Foundation, which authored the conservative Project […] Continue reading -> Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Why HIV Could Be Poised for a Monumental Comeback 21/01/2025 Beatriz Grinsztejn & Birgit Poniatowski The good news first: HIV science has made remarkable progress. While we still lack a vaccine or cure, a single dose of a new long-acting injectable drug can now offer protection against HIV for up to six months. This breakthrough could revolutionize efforts to curb a pandemic that still claims a life every minute. However, […] Continue reading -> Unhappy About ‘Woke Agenda’ of PEPFAR, US Conservatives Finally Have Pretext to Cut HIV Funds 19/01/2025 Kerry Cullinan Influential conservatives have long sought to curtail the United States President’s Emergency Plan for AIDS Relief (PEPFAR) – and the actions of four nurses in Mozambique may have inadvertently given them the ammunition to do just that. Deeply uncomfortable with the sexual dimension of HIV transmission, the powerful Heritage Foundation, which authored the conservative Project […] Continue reading -> Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unhappy About ‘Woke Agenda’ of PEPFAR, US Conservatives Finally Have Pretext to Cut HIV Funds 19/01/2025 Kerry Cullinan Influential conservatives have long sought to curtail the United States President’s Emergency Plan for AIDS Relief (PEPFAR) – and the actions of four nurses in Mozambique may have inadvertently given them the ammunition to do just that. Deeply uncomfortable with the sexual dimension of HIV transmission, the powerful Heritage Foundation, which authored the conservative Project […] Continue reading -> Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pepfar and Global Fund Target Rollout of HIV Prevention Injectable 17/12/2024 Kerry Cullinan Some two million people may get access to lenacapavir, the twice-yearly antiretroviral injection that prevents HIV injection, within the next three years, thanks to the Global Fund and United States President’s Emergency Plan for AIDS Relief (PEPFAR). The initiative is contingent upon regulatory approval from the US Food and Drug Administration (FDA), national pharmaceutical regulators, […] Continue reading -> Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Amid Global HIV Funding Challenges, PEPFAR Head Will Resign Before Trump Takes Office 03/12/2024 Kerry Cullinan As a political appointee, Ambassador John Nkengasong, head of the US President’s Emergency Plan for AIDS Relief (PEPFAR), said that he will be obliged to resign when President-elect Donald Trump is inaugurated on 20 January. “The rules that govern a transition are that all the political appointees have to resign on the 20th and then […] Continue reading -> Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Transformative Potential of Long-Acting Preventive Drugs Takes Centre Stage at HIV Conference 14/10/2024 Edith Magak LIMA, Peru – The infection-prevention potential of Lenacapavir, the long-acting anti-HIV injectable administered just twice a year, took centre stage at the fifth HIV Research for Prevention Conference (HIVR4P) held last week. However, several other important studies were also unveiled, including an injectable that combines contraception and HIV protection, results from a three-month vaginal ring, […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Progress to End AIDS in Georgia ‘Threatened’ by New Anti-LGBTQ+ Law 01/10/2024 Sophia Samantaroy UNAIDS expressed “deep concern” Wednesday over Georgia’s newly adopted anti-LGBTQ+ law, saying that it could threaten progress made over the past decade to end AIDS in the former Soviet republic of 3.7 million people at the crossroads between Europe and Asia. The new legislation exacerbates stigma and hinders “LGBTQ+ people’s access to essential health services” […] Continue reading -> Posts navigation Older postsNewer posts